| Literature DB >> 22073375 |
M I Dávila-Rodríguez1, E I Cortés Gutiérrez, R M Cerda Flores, M Pita, J L Fernández, C López-Fernández, J Gosálvez.
Abstract
Whole comparative genomic hybridization (W-CGH) is a new technique that reveals cryptic differences in highly repetitive DNA sequences, when different genomes are compared using metaphase or interphase chromosomes. W-CGH provides a quick approach to identify differential expansion of these DNA sequences at the single-chromosome level in the whole genome. In this study, we have determined the frequency of constitutive chromatin polymorphisms in the centromeric regions of human chromosomes using a whole-genome in situ cross-hybridization method to compare the whole genome of five different unrelated individuals. Results showed that the pericentromeric constitutive heterochromatin of chromosome 6 exhibited a high incidence of polymorphisms in repetitive DNA families located in pericentromeric regions. The constitutive heterochromatin of chromosomes 5 and 9 was also identified as highly polymorphic. Although further studies are necessary to corroborate and assess the overall incidence of these polymorphisms in human populations, the use of W-CGH could be pertinent and of clinical relevance to assess rapidly, from a chromosomal viewpoint, genome similarities and differences in closely related genomes such as those of relatives, or in more specific situations such as bone marrow transplantation where chimerism is produced in the recipient.Entities:
Keywords: W-CGH.; comparative genomics; constitutive heterochromatin; human chromosomes; whole comparative genomic hybridization
Mesh:
Substances:
Year: 2011 PMID: 22073375 PMCID: PMC3203469 DOI: 10.4081/ejh.2011.e28
Source DB: PubMed Journal: Eur J Histochem ISSN: 1121-760X Impact factor: 3.188
Combinations of five different DNA samples labeled with digoxigenin and biotin and cohybridized on the chromosomes of a predefined individual. This results in nine different experiments.
| DNA labelling with biotine | DNA labelling with digoxigenin | |||||
|---|---|---|---|---|---|---|
| IND 1 | IND 2 | IND 3 | IND 4 | IND 5 | ||
| IND 1 | REF | EXP 1 | EXP 2 | EXP 3 | EXP 4 | |
| IND 2 | X | REF | EXP 5 | EXP 6 | EXP 7 | |
| IND 3 | X | X | REF | EXP 8 | EXP 9 | |
EXP, experiment; REF, reference; IND, individual.
Figure 1A) W-CGH in a human metaphase spread showing differential green or red dominance; B) chromosome 5 selected from the metaphase spread depicted in A shows red dominance; C) W-CGH in a human metaphase spread, where the pericentromeric heterochromatin blocks showed similar green and red fluorescence (yellow); D) chromosome 5 selected from the metaphase shown in C. The G/R ratio is indicated to the right of each chromosome. A and C scale bars: 10 µm; B and D scale bars: 5 µm.
Descriptive statistics for G/R variation in the nine different experiments.
| Experiment | X±SD | Maximum | Minimum | Range |
|---|---|---|---|---|
| 1 | 0.73±0.08 | 0.87 | 0.64 | 0.23 |
| 1′ | 1.03±0.014 | 1.05 | 1.02 | 0.03 |
| 2 | 1.03±0.41 | 1.98 | 0.67 | 1.31 |
| 2′ | 1.01±0.05 | 1.08 | 0.96 | 0.12 |
| 3 | 0.77±0.12 | 0.86 | 0.54 | 0.32 |
| 3′ | 0.98±0. 02 | 1.01 | 0.95 | 0.58 |
| 4 | 0.68±0.08 | 0.77 | 0.52 | 0.25 |
| 4′ | 1.03±0.04 | 1.09 | 1.00 | 0.86 |
| 5 | 0.88±0.21 | 1.32 | 0.61 | 0.71 |
| 5′ | 1.03±0.03 | 1.06 | 1.00 | 0.05 |
| 6 | 0.97±0.25 | 1.33 | 0.71 | 0.62 |
| 6′ | 1.01±0.00 | 1.01 | 1.01 | 0.00 |
| 7 | 1.17±0.18 | 1.47 | 0.72 | 0.75 |
| 7′ | 1.01±0.02 | 1.02 | 1.00 | 0.02 |
| 8 | 1.05±0.29 | 1.53 | 0.63 | 0.90 |
| 8′ | 0.99±0.02 | 1.01 | 0.98 | 0.03 |
| 9 | 1.07±0.26 | 1.41 | 0.73 | 0.68 |
| 9′ | 1.11±0.26 | 1.13 | 1.09 | 0.03 |
| Y-chromosome | 0.50±0.44 | 1.16 | 0.19 | 0.96 |
1 to 9, polymorphic chromosomes; 1′ to 9′, nonpolymorphic chromosomes.
Values of D/B in 22 autosomes, chromosome-X, and chromosome-Y in nine different experiments.
| Chromosome | EXP 1 | EXP 2 | EXP 3 | EXP 4 | EXP 5 | EXP 6 | EXP 7 | EXP 8 | EXP 9 | TOTAL |
|---|---|---|---|---|---|---|---|---|---|---|
| W-CGH | ♀D/♂B | ♀D/♀B | ♀D/♀B | ♀D/♀B | ♀D/♂B | ♀D/♂B | ♀D/♂B | ♀D/♀B | ♀D/♀B | |
| 1 | 1 | 1 | 0.73/0.77 | 1 | 1 | 0.81/0.83 | 1 | 1 | 1 | 2 |
| 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 3 | 0.76/0.79 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 4 | 1 | 1 | 1 | 1 | 1 | 1.16/1.22 | 1 | 1 | 1 | 1 |
| 5 | 1 | 1 | 1 | 0.67/0.73 | 0.78/0.86 | 1 | 1 | 1.33/1.40 | 1.27/1.27 | 4 |
| 6 | 1 | 1 | 0.73/0.77 | 1.15/1.11 | 1.23/1.32 | 1 | 1.18/1.03 | 1 | 1.26/1.26 | 5 |
| 7 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 8 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 9 | 1 | 0.81/0.80 | 1 | 1 | 1 | 1.12/1.13 | 0.74/0.71 | 1 | 1 | 3 |
| 10 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 11 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 12 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 13 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 14 | 1 | 0.74/0.83 | 0.75/0.79 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 15 | 0.71/0.71 | 0.67/0.68 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 16 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 17 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 18 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 19 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.27/1.37 | 1 |
| 20 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 21 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| 22 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.72/0.75 | 1 |
| X | ND | 1 | 1 | 1 | ND | ND | ND | 1 | 1 | 0 |
| Y | 0.33 | ND | ND | ND | 0.22 | 0.32 | 0.28 | ND | ND | 4 |
Chromosomes with D/B values <0.90 and >1.10 are considered polymorphic; total, number of chromosomes polymorphic in the experiments.